SCHEMBL6556705

SCHEMBL6556705

CCC(CO)(COC)COC

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.30
TSHR P16473 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10085652 0.94 ALDH1A1 (0.30) ALDH1A1TSHR
SCHEMBL139205 0.94 ALDH1A1 (0.30) ALDH1A1TSHR
SCHEMBL26792741 0.91 THRB (0.35)
SCHEMBL14683257 0.91 THRB (0.32)
SCHEMBL26792715 0.91 THRB (0.32)
SCHEMBL14683260 0.91 THRB (0.32)
SCHEMBL18312178 0.89 THRB (0.34)
SCHEMBL18309144 0.87 THRB (0.33)
SCHEMBL14891876 0.87
SCHEMBL18309137 0.87 THRB (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1190866-B1 Photocrosslinkable latex protective overcoat for imaging elements EASTMAN KODAK CO (US) 2004-03-03 EP claimed
EP-1190866-A1 Photocrosslinkable latex protective overcoat for imaging elements EASTMAN KODAK COMPANY (US) 2002-03-27 EP claimed
US-6352805-B1 IMAGED ELEMENT HAVING PROTECTIVE OVERCOAT OF COMPOSITION COMPRISING REACTION PRODUCT OF WATER-DISPERSIBLE LATEX PARTICLES AND COPOLYMERIZABLE MULTIFUNCTIONAL MONOMER CROSSLINKED WITH ULTRAVIOLET LIGHT IN PRESENCE OF INITIATOR EASTMAN KODAK COMPANY 2002-03-05 US claimed
US-20160354476-A1 TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE IONIS PHARMACEUTICALS, INC. (US) 2016-12-08 US disclosed
US-9442431-B2 Intermediate transfer member, imaging apparatus, and method EASTMAN KODAK COMPANY (US) 2016-09-13 US disclosed
US-20160017323-A1 CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE ISIS PHARMACEUTICALS, INC. (US) 2016-01-21 US disclosed
US-9163239-B2 Compositions and methods for modulating apolipoprotein C-III expression ISIS PHARMACEUTICALS, INC. (US) 2015-10-20 US disclosed
US-20150126719-A1 COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2015-05-07 US disclosed
US-20150126720-A1 COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN (a) EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 2015-05-07 US disclosed
US-8649724-B2 Cleaning blade member and apparatus with controlled tribocharging EASTMAN KODAK COMPANY (US) 2014-02-11 US disclosed
US-20120301197-A1 CLEANING BLADE MEMBER AND APPARATUS WITH CONTROLLED TRIBOCHARGING BANK OF AMERICA, N.A., AS AGENT 2012-11-29 US disclosed
US-6395459-B1 CURING; WATERPROOF PROTECTIVE COATING EASTMAN KODAK COMPANY 2002-05-28 US disclosed
EP-1193551-A2 A method of forming a protective overcoat for imaged elements and related articles EASTMAN KODAK COMPANY (US) 2002-04-03 EP disclosed
EP-1190866-A1 Photocrosslinkable latex protective overcoat for imaging elements EASTMAN KODAK COMPANY (US) 2002-03-27 EP disclosed
US-6352805-B1 IMAGED ELEMENT HAVING PROTECTIVE OVERCOAT OF COMPOSITION COMPRISING REACTION PRODUCT OF WATER-DISPERSIBLE LATEX PARTICLES AND COPOLYMERIZABLE MULTIFUNCTIONAL MONOMER CROSSLINKED WITH ULTRAVIOLET LIGHT IN PRESENCE OF INITIATOR EASTMAN KODAK COMPANY 2002-03-05 US disclosed
EP-0367464-B1 Production of polyester polymers and aqueous dispersions thereof ZENECA LTD (GB) 1995-06-07 EP disclosed
US-5021544-A Having pendant polyoxyalkylene chains; stability IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-06-04 US disclosed
EP-0367464-A2 Production of polyester polymers and aqueous dispersions thereof ZENECA LIMITED (GB) 1990-05-09 EP disclosed
EP-0232016-A2 Curable coating compositions and their preparation and use IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-08-12 EP disclosed
US-4107013-A INDUSTRIAL COATINGS; HIGH MOLECULAR WEIGHT POLYMER AND LOW MOLECULAR WEIGHT CROSSLINKING POLYMER SCM CORPORATION (US) 1978-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160354476-A1 TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE FUT6, GALNT6, FUT5 ALDH1A1 1445/4885TSHR 3307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.